Notably, results showed significantly higher prelamin A and lower RAD51 levels in pR0 compared to pR2 cervical tumors (p<0.05 for both, Figure 1C and 1G), and the Spearman’s Rank analysis showed a significant negative correlation between the level of the two biomarkers (r= -0.6, p<0.05). The gene discussed is RAD51; the disease is uterine cervix neoplasm.